Overview
Legal name
SYNTHOMER PLC
Region
East of England
Registered address
TEMPLE FIELDS
HARLOW
ESSEX
CM20 2BH
Insolvency history
No
Company
Active
PLC
Company profile
Synthomer PLC
Home | Synthomer
Our specialised, emissions-reducing formulations help customers make thousands of products that bind the modern world together.
CRN
00098381
Founded
1908
Age
118
Corporate ownership
Updated 06 Jun 2026 16:52
Synthomer PLC
No active corporate controller recorded.
Company events
Reference milestones and recent Companies House filing stream events.
10 events
15 Oct
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
30 Jun
2026
Accounts due
Accounts DueNext accounts due date
22 May
2026
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzUyMzI2ODQ3OGFkaXF6a2N4
Published 22 May 2026 12:14
01 Oct
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
01 Oct
2024
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzNzk3NTQ0M2FkaXF6a2N4
Published 01 Oct 2024 02:21
04 Sep
2024
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzNDUwOTEwMWFkaXF6a2N4
Published 04 Sep 2024 15:39
04 Sep
2024
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzNDUwODAyM2FkaXF6a2N4
Published 04 Sep 2024 15:28
09 Aug
2024
Accounts With Accounts Type Group
Accounts PDF pendingAA | Transaction MzQzMTY5NjU0NWFkaXF6a2N4 | Paper/PDF filed
Published 10 Aug 2024 07:53
16 Jun
1908
Incorporated
InceptionCompany registered at Companies House
Public funding
3 awards
First funded
2006
Funded years
2006, 2013, 2015
Age at first award
98 years
Projects
2015
Collaborative R&D
A naturally inspired industrial biotechnology route to the manufacture of a novel biopolymer with unique properties
1 Apr 2015 to 31 Mar 2017
Awarded
£74,976
Total cost £149,952
Synthomer and Ingenza will continue the collaboration begun in a successful TSB co-funded Feasibility Study. Synthomer have identified a market gap for a product which if made using industrial biotechnology would have improved properties and none of the drawbacks of similar materials made by existing manufacturing technologies. They anticipate that this p...
2013
Feasibility Studies
Feasibility study for a new industrial biotech bioprocess for the manufacture of a novel biopolymer with unique properties
1 May 2013 to 31 Mar 2014
Awarded
£37,952
Total cost £58,396
Synthomer have identified a market gap for a product which if made using industrial biotechnology would have improved properties and none of the drawbacks of similar materials made by existing manufacturing technologies. They anticipate that this product would be rapidly assimilated into one of their key market areas and leverage market acceptance due the...
2006
Collaborative R&D
SMART LATEXES FROM MINI-EMULSIONS
1 Oct 2006 to 30 Sep 2009
Awarded
£250,000
Total cost £694,926
Awaiting Public Summary
Product types
Collaborative R&D
Feasibility Studies